U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356089) titled 'Twiist Postmarket Surveillance Study for Type 1 Diabetes' on Jan. 06.
Brief Summary: The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.
Study Start Date: Dec. 09, 2025
Study Type: OBSERVATIONAL
Condition:
Type 1 Diabetes (T1D)
Type 1 Diabetes Mellitus
Intervention:
DEVICE: twiist Automated Insulin Delivery System
twiist(TM) system includes a novel insulin pump, a CGM sensor, and the glycemic-control algorithm
Recruitment Status: RECRUITING
Sponsor: Deka Research and Development
Disclaimer: Curated by HT Syndication....